CTAs are almost max long in equities, have very limited room to buy: UBS
Director of e.l.f. Beauty, Inc. (NYSE:ELF), Lauren Cooks Levitan, sold 4,630 shares of common stock on August 14, 2025, for a total of $550,676. The shares were sold in a price range of $118.84 to $118.97. The transaction comes as the company’s stock shows significant momentum, with a remarkable 71% return over the past six months. According to InvestingPro analysis, the stock is currently trading near Fair Value, with notable price volatility in recent months.
On the same day, Levitan also exercised options to acquire 3,440 shares of e.l.f. Beauty common stock at a price of $8.23, for a total value of $28,311. The company maintains strong financial health with a current ratio of 3.26, indicating robust liquidity. For deeper insights into insider trading patterns and 17+ additional ProTips, explore the comprehensive research available on InvestingPro.
In other recent news, e.l.f. Beauty reported a 9.0% year-over-year increase in sales for the fiscal first quarter of 2026, reaching $353.7 million, slightly surpassing consensus estimates of 8.5% growth. Adjusted earnings per share were $0.89, exceeding expectations of $0.84. Following the company’s acquisition of Rhode, BofA Securities maintained its Buy rating with a price target of $135, adjusting its fiscal 2026 sales growth forecast to 25% due to the acquisition and international expansion. Meanwhile, Canaccord Genuity lowered its price target to $128 from $150, citing concerns over tariffs but maintained a Buy rating. Morgan Stanley (NYSE:MS) upgraded e.l.f. Beauty to Overweight from Equalweight, raising the price target to $134, noting the stock’s volatility as an attractive entry point. Similarly, Deutsche Bank (ETR:DBKGn) upgraded the stock to Buy after a 9.5% drop, maintaining a price target of $121, viewing the price level as an attractive entry point with potential upside. These developments highlight the varied analyst perspectives on e.l.f. Beauty’s recent performance and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.